AVRO stock performance?

Averion International Corp (AVRO) news stock charts

Averion International Corp (AVRO) Investment Summary:

Averion International Corp., an international clinical research organization, focuses on providing clinical research services and solutions for the drug development lifecycle. The company offers strategic consulting, product agency registration support, trial design, site selection, project management, medical and site monitoring, data management, biostatistical analysis and reporting, pharmacovigilance, medical writing, and clinical trial management and consulting services for the clinical trials lifecycle. It also provides strategic research planning, regulatory planning, program planning/clinical trial design, site selection/patient recruitment, quality assurance and auditing, data monitoring and clinical endpoint committees, clinical site monitoring, and clinical project management services. The company serves pharmaceutical, biotechnology, and medical device industries. The company provides its services in the United States and Europe. Averion International Corp. is headquartered in Southborough, Massachusetts with additional offices in New York, Maryland, California, Switzerland, France, the Netherlands, the United Kingdom, Poland, the Russian Federation, Israel, Germany, Austria, Hungary, the Czech Republic, and Ukraine.
www.averionintl.com
440 Employees

AVERION INTERNATIONAL CORP (AVRO:OTC)

LAST $0.0040 USD
CHANGE TODAY 0.00 0.00%
VOLUME 0.0
As of 8:10 PM 03/15/10 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of AVERION INTERNATIONAL CORP (AVRO)

OPEN
$0.0040
PREVIOUS CLOSE
$0.0040
DAY HIGH
$0.0040
DAY LOW
$0.0040
52 WEEK HIGH
03/20/09 - $0.03
52 WEEK LOW
01/28/10 - $0.0010
MARKET CAP
2.6M
AVERAGE VOLUME 10 D
2.9K
EPS TTM
$-0.03
SHARES OUTSTANDING
639.3M
AVRO Does Not Pay Dividends
P/E TTM
--
K = Thousands  M = Millions  B = Billions

Key developments for AVERION INTERNATIONAL CORP (AVRO)

Averion International Corp. has Changed its Ticker to AVRO from AVROD

Effective February 04, 2010, Averion International Corp. changed its OTCPK stock ticker symbol to AVRO from AVROD.

Averion International Corp. will Change its Ticker to AVROD from AVRO

Effective January 07, 2010, Averion International Corp. will change its OTCPK stock ticker symbol to AVROD from AVRO.

Averion International Deleted From OTCBB

Averion International Corps common stock has been deleted from OTC Bulletin Board effective December 17, 2009 on account of its filing Form 15. The company has been added other NBB.

Averion International Corp financial resources

otc, otcbb, pinksheet, AVRO, ob Averion International Corp

AVRO Competitors

Company Last Change
Covance Inc $60.93 USD +0.15
ICON PLC €18.60 EUR +0.45
Kendle International Inc $17.19 USD -0.51
Parexel International Corp $23.16 USD -0.44
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation AVRO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

AVRO

 | 

AVRO transactions

Type
Date
Target
No transactions in the last 6 months.

More Recent Financial News About Averion International Corp

AVERION INTERNATIONAL CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a

Quote: Results of Operations and Financial Condition On March 30, 2009, Averion International Corp. (the "Company") announced its financial results for the fiscal quarter and fiscal year ended December 31, 2008. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities ...
Read article

AVERION INTERNATIONAL CORP. Files SEC form 10-K, Annual Report

Quote: Although the expansion of our client base through the acquisitions of Averion Inc. and Hesperion Ltd. has increased our revenues, the loss of business from any of our major clients could have a material adverse effect on our financial position and consolidated statements of operations. Our revenue growth has and will continue to be highly dependent on our ability to attract, develop, motivate and retain skilled professionals. We closely monitor our overall attrition rates and patterns to ensure ...
Read article

AVERION INTERNATIONAL CORP. Files SEC form 10-Q, Quarterly Report

Quote: Although the expansion of our client base through the acquisitions of Averion Inc. and Hesperion has increased our revenues, the loss of business from any of our major clients could have a material adverse effect on us. Our revenue growth has and will continue to be highly dependent on our ability to attract, develop, motivate and retain skilled professionals. We closely monitor our overall attrition rates and patterns to ensure our personnel management strategy aligns with our growth objective...
Read article

AVERION INTERNATIONAL CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial St

Quote: NJK is an affiliate of Cumulus Investors, LLC, Averion's second largest stakeholder. Mr. McGuire also spent 12 years with Control Data Corporation and was a Vice President in the Peripherals Group. Mr. McGuire was a director of Digital Insight Corporation from its inception in 1997, was chairman until 1999, and served on the Board until its sale to Intuit, Inc. in early 2007. Mr. McGuire also was a director of Laureate Education Inc., a higher education company, from 1995 until 2007 when it was ...
Read article

AVERION INTERNATIONAL CORP. Files SEC form 10-Q, Quarterly Report

Quote: We believe the expansion of our business through the acquisition of established CROs enables us to provide a multitude of services sooner and more effectively than if we were to build such services organically. Averion International Corp. was originally organized under the name Clinical Trials Assistance Corporation ("Clinical Trials") by the filing of Articles of Incorporation with the Secretary of State of the State of Nevada on April 22, 2002. On June 14, 2004, Clinical Trials acqui...
Read article

AVERION INTERNATIONAL CORP. Files SEC form 10-Q, Quarterly Report

Quote: Although the expansion of our client base through the acquisitions of Averion Inc. and Hesperion has increased our revenues, the loss of business from any of our major clients could have a material adverse effect on us. Our revenue growth has and will continue to be highly dependent on our ability to attract, develop, motivate and retain skilled professionals. We closely monitor our overall attrition rates and patterns to ensure our personnel management strategy aligns with our growth objective...
Read article

Averion Announces Going Private Transaction

Quote: Followingthe transaction, the Company expects to have fewer than 300 shareholdersof record as defined by SEC rules, which will enable the Company tocease registration of its common stock under the 1934 Securities Act.Effective on and following the termination of the registration of theCompany’s common stock under the 1934 Act, the Company will no longer berequired to file annual, quarterly and other reports with the SEC.Commenting on this development, James McGuire, Chairman of the Board,...
Read article

Would you like to leave a comment about Averion International Corp AVRO

Besides Averion International Corp's Stock there is more great penny stock and market information at Realpennies